CAR T cells also recognized and killed CD133-positive glioma-initiating cells, prevented neurosphere formation, and were able to destroy preformed neurospheres, demonstrating that radiation/chemotherapy-resistant glioma-initiating cells are sensitive to this immune-mediated killing mechanism (59, 60, 63, 64). Here, PROM1 is linked to central nervous system cancer.